These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34659345)

  • 1. Prognostic Value of Immune-Related Multi-IncRNA Signatures Associated With Tumor Microenvironment in Esophageal Cancer.
    Pang J; Pan H; Yang C; Meng P; Xie W; Li J; Li Y; Xiao SY
    Front Genet; 2021; 12():722601. PubMed ID: 34659345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
    Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
    Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.
    Huai Q; Guo W; Han L; Kong D; Zhao L; Song P; Peng Y; Gao S
    Transl Cancer Res; 2021 Apr; 10(4):1787-1803. PubMed ID: 35116502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
    Yao Y; Xuan H; Wang J; Gong L; Gao W
    Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 7. The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma.
    Liu Y; Wang L; Liu H; Li C; He J
    Front Oncol; 2020; 10():61. PubMed ID: 32133283
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma.
    Li X; Wang Y; Min Q; Zhang W; Teng H; Li C; Zhang K; Shi L; Wang B; Zhan Q
    Comput Struct Biotechnol J; 2023; 21():3841-3853. PubMed ID: 37564101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparative Analysis of the Gene Expression Profiles of Small Cell Esophageal Carcinoma, Small Cell Lung Cancer, and Esophageal Adeno/Squamous Carcinoma.
    Liu D; Wen J; Chen J; Wang B; Xu X; Zhang Z; Fan M
    Front Surg; 2021; 8():655159. PubMed ID: 34395507
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development.
    Lu T; Xu R; Wang CH; Zhao JY; Peng B; Wang J; Zhang LY
    Front Genet; 2022; 13():853113. PubMed ID: 35734437
    [No Abstract]   [Full Text] [Related]  

  • 11. The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance.
    Li Z; Zheng C; Huang L; Yin X; Wang Z; Liu C; Li B
    Ann Transl Med; 2022 Dec; 10(24):1347. PubMed ID: 36660671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal Adenocarcinoma.
    Zhu L; Yang F; Li X; Li Q; Zhong C
    Front Genet; 2021; 12():743133. PubMed ID: 34956314
    [No Abstract]   [Full Text] [Related]  

  • 15. Stratification From Heterogeneity of the Cell-Death Signal Enables Prognosis Prediction and Immune Microenvironment Characterization in Esophageal Squamous Cell Carcinoma.
    Zhang Y; Chen Y
    Front Cell Dev Biol; 2022; 10():855404. PubMed ID: 35493093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-Related Long Non-coding RNA Signature and Clinical Nomogram to Evaluate Survival of Patients Suffering Esophageal Squamous Cell Carcinoma.
    Zhu T; Ma Z; Wang H; Wei D; Wang B; Zhang C; Fu L; Li Z; Yu G
    Front Cell Dev Biol; 2021; 9():641960. PubMed ID: 33748133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a Novel Risk Score System of Immune Genes Associated With Prognosis in Esophageal Carcinoma.
    Fei Z; Xie R; Chen Z; Xie J; Gu Y; Zhou Y; Xu T
    Front Oncol; 2021; 11():625271. PubMed ID: 33859939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the immune infiltrate and patient outcomes in esophageal cancer.
    Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
    Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival-associated alternative splicing signatures in esophageal carcinoma.
    Mao S; Li Y; Lu Z; Che Y; Sun S; Huang J; Lei Y; Wang X; Liu C; Zheng S; Zang R; Li N; Li J; Sun N; He J
    Carcinogenesis; 2019 Mar; 40(1):121-130. PubMed ID: 30304323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment and validation of prognostic risk score model for esophageal squamous cell carcinoma based on immune related genes].
    Liu HR; Jiang GZ; Xin D; Yang YL; Fan QX; Meng XR; Li SL; Liu Y; Xia J; Wang F
    Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):666-673. PubMed ID: 34289558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.